Samuel B. Drory

Samuel B. Drory

Auto-generated profile, based on publicly available information

Samuel B. Drory

Institut Universitaire de Cardiologie et de Pneumologie de Québec Université Laval Québec Canada

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
ESErwan Salaun
Erwan Salaun
SDSamuel Drory
Samuel Drory
MCMarc‐André Coté
Marc‐André Coté
VTVeronic Tremblay
Veronic Tremblay
EBElisabeth Bédard
Elisabeth Bédard
STSébastien Thériault
Sébastien Thériault
Cardiac troponin is extensively used as a biomarker in modern medicine due to its diagnostic capability for myocardial injury, as well as its predictive and prognostic value for cardiac diseases. However, heterophile antibodies, antitroponin antibodies, and macrotroponin complexes can be observed both in seemingly healthy individuals and patients with cardiac diseases, potentially leading to false positive or disproportionate elevation of cTn (cardiac troponin) assay results and introducing discrepancies in clinical interpretations with impact on medical management. In this review article, we describe the possible mechanisms of cTn release and the sources of variations in the assessment of circulating cTn levels. We also explore the pathophysiological mechanisms underlying antitroponin antibody development and discuss the influence exerted by macrotroponin complexes on the results of immunoassays. Additionally, we explore approaches to detect these complexes by presenting various clinical scenarios encountered in routine clinical practice. Finally, unsolved questions about the development, prevalence, and clinical significance of cardiac autoantibodies are discussed.

4 February 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HEHeather E. Eaton
Heather E. Eaton
GDGuillaume Desrochers
Guillaume Desrochers
SDSamuel B. Drory
Samuel B. Drory
JMJulie Metcalf
Julie Metcalf
AAAnnie Angers
Annie Angers
CBCraig Brunetti
Craig Brunetti
LITAF is a small cellular protein with an unknown function. The C-terminus of LITAF contains a highly conserved domain termed the SIMPLE-like domain (SLD), while the N-terminus contains two PPXY motifs that mediate protein-protein interactions with WW-domain containing proteins. LITAF also harbors two endosome/lysosome targeting sequences at its C-terminus, but there has been conflicting reports regarding its intracellular localization. Here, we demonstrate that LITAF is localized to the late endosome/lysosomal compartment in a variety of cell lines. We also show that Itch, a WW-domain containing protein, and LITAF strongly interact and that this interaction depends on the two PPXY motifs in the N-terminus of LITAF. Interestingly, co-expression of LITAF with Itch induces major changes in Itch intracellular localization, bringing Itch from the trans-Golgi network to lysosomes. We show that this re-localization is dependent upon the interaction with the PPXY sequences of LITAF, since disruption of these binding motifs completely abrogates Itch re-localization.